Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
暂无分享,去创建一个
Shashank Garg | Yang Song | W. F. Fricke | Erik C von Rosenvinge | G. Berg | S. Dutta | Yang Song | C. Maddox | W. Florian Fricke | M. Girotra | S. Garg | Anand Dutta | Mohit Girotra | Cynthia Maddox | Erik C. von Rosenvinge | Sudhir Dutta | Anandi Dutta | W. Florian Fricke
[1] P. Gajer,et al. Vaginal microbiome of reproductive-age women , 2010, Proceedings of the National Academy of Sciences.
[2] Wolfgang Ludwig,et al. Revised road map to the phylum Firmicutes , 2015 .
[3] J. Pohl. Clostridium difficile infection and proton pump inhibitors , 2012, Current opinion in pediatrics.
[4] T. Borody,et al. Fecal microbiota transplantation and emerging applications , 2012, Nature Reviews Gastroenterology &Hepatology.
[5] David R. Riley,et al. CloVR: A virtual machine for automated and portable sequence analysis from the desktop using cloud computing , 2011, BMC Bioinformatics.
[6] Katherine H. Huang,et al. Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.
[7] J. Bartlett,et al. Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile Infection. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[8] W. D. de Vos,et al. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. , 2004, International journal of systematic and evolutionary microbiology.
[9] Lynne V McFarland,et al. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease , 2002, American Journal of Gastroenterology.
[10] J. Jansson,et al. Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea , 2009, Journal of clinical gastroenterology.
[11] Vincent B. Young,et al. Suppression of Clostridium difficile in the Gastrointestinal Tracts of Germfree Mice Inoculated with a Murine Isolate from the Family Lachnospiraceae , 2012, Infection and Immunity.
[12] John D Lambris,et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. , 2011, Cell host & microbe.
[13] W. M. Vos,et al. Microbes inside—from diversity to function: the case of Akkermansia , 2012, The ISME Journal.
[14] C. Kelly,et al. Clostridium difficile--more difficult than ever. , 2008, The New England journal of medicine.
[15] D. Musher,et al. Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide. , 2007, The Journal of antimicrobial chemotherapy.
[16] D. Relman,et al. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation , 2010, Proceedings of the National Academy of Sciences.
[17] R Balfour Sartor,et al. Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.
[18] J. Castilla,et al. Challenges in the Quest for Keystones , 1996 .
[19] A. Berstad,et al. [Clostridium difficile-associated diarrhea treated with homologous feces]. , 1998, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[20] G. Gloor,et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut , 2013, Microbiome.
[21] G. Tannock,et al. Nucleic acid-based methods to assess the composition and function of the bowel microbiota. , 2012, Gastroenterology clinics of North America.
[22] W. Petritsch,et al. Alteration of Intestinal Dysbiosis by Fecal Microbiota Transplantation Does not Induce Remission in Patients with Chronic Active Ulcerative Colitis , 2013, Inflammatory bowel diseases.
[23] W. Roediger. Utilization of nutrients by isolated epithelial cells of the rat colon. , 1982, Gastroenterology.
[24] D. Gerding,et al. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] D. Gerding,et al. Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment. , 2009, Anaerobe.
[26] V. Mai,et al. Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea , 2013, Journal of Clinical Microbiology.
[27] Luying Peng,et al. Effects of Butyrate on Intestinal Barrier Function in a Caco-2 Cell Monolayer Model of Intestinal Barrier , 2007, Pediatric Research.
[28] C. Surawicz,et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] L. Brandt,et al. Clostridium difficile Infection and Inflammatory Bowel Disease , 2013, Journal of clinical gastroenterology.
[30] Matthew J. Hamilton,et al. High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria , 2013, Gut microbes.
[31] E. van Nood,et al. Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease? , 2013, Best practice & research. Clinical gastroenterology.
[32] K. Garey,et al. Rifaximin in Treatment of Recurrent Clostridium difficile-associated Diarrhea: An Uncontrolled Pilot Study , 2009, Journal of clinical gastroenterology.
[33] S. Maroo,et al. Recurrent clostridium difficile. , 2006, Gastroenterology.
[34] S. O'keefe. Tube feeding, the microbiota, and Clostridium difficile infection. , 2010, World journal of gastroenterology.
[35] Taane G. Clark,et al. Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice , 2012, PLoS pathogens.
[36] J. Rombeau,et al. Parenteral nutrition supplemented with short-chain fatty acids: effect on the small-bowel mucosa in normal rats. , 1990, The American journal of clinical nutrition.
[37] J. Bakken,et al. Treating Clostridium difficile infection with fecal microbiota transplantation. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[38] A. Manges,et al. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[39] James R. White,et al. CloVR-16S: Phylogenetic microbial community composition analysis based on 16S ribosomal RNA amplicon sequencing – standard operating procedure, version 1.0 , 2011 .
[40] Martin Hartmann,et al. Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.
[41] J. Tiedje,et al. Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.
[42] D. Anderson,et al. Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals , 2011, Infection Control & Hospital Epidemiology.
[43] R. Xavier,et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 , 2009, Nature.
[44] G. Garrity. Bergey’s Manual® of Systematic Bacteriology , 2012, Springer New York.
[45] T. Stukel,et al. Reduction in Clostridium difficile Infection Rates after Mandatory Hospital Public Reporting: Findings from a Longitudinal Cohort Study in Canada , 2012, PLoS medicine.
[46] U. Navaneethan,et al. Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship. , 2010, World journal of gastroenterology.
[47] S. Routhier,et al. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[48] B. Ebenman,et al. Using community viability analysis to identify fragile systems and keystone species. , 2005, Trends in ecology & evolution.
[49] Stuart Johnson,et al. An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.
[50] J. Bakken,et al. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] Paramvir S. Dehal,et al. FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments , 2010, PloS one.
[52] Gerhard G. Thallinger,et al. Alterations in the Colonic Microbiota in Response to Osmotic Diarrhea , 2013, PloS one.
[53] J. Silva,et al. Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin. , 1987, Journal of clinical gastroenterology.
[54] T. Lamont,et al. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. , 2010, Journal of pediatric gastroenterology and nutrition.
[55] K. Whelan,et al. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease , 2012, Alimentary pharmacology & therapeutics.
[56] J. Bartlett,et al. Clinical practice. Antibiotic-associated diarrhea. , 2002, New England Journal of Medicine.
[57] Gaurav Agrawal,et al. Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions , 2013, Current Gastroenterology Reports.
[58] Wolfgang Ludwig,et al. Revised road map to the phylum Firmicutes , 2015 .
[59] Emma Allen-Vercoe,et al. Toward an Understanding of Changes in Diversity Associated with Fecal Microbiome Transplantation Based on 16S rRNA Gene Deep Sequencing , 2012, mBio.
[60] William A. Walters,et al. QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.
[61] N. Fairweather,et al. Antibiotic Treatment of Clostridium difficile Carrier Mice Triggers a Supershedder State, Spore-Mediated Transmission, and Severe Disease in Immunocompromised Hosts , 2009, Infection and Immunity.
[62] E. Zoetendal,et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. , 2012, Gastroenterology.
[63] Mihai Pop,et al. Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples , 2009, PLoS Comput. Biol..
[64] Bernard Zenko,et al. Gut Microbiota Patterns Associated with Colonization of Different Clostridium difficile Ribotypes , 2013, PloS one.
[65] B. Sheppard,et al. Clostridium difficile colitis: an increasing hospital-acquired illness. , 1995, American journal of surgery.
[66] A. Berman. Efficacy of rifaximin and vancomycin combination therapy in a patient with refractory Clostridium difficile-associated diarrhea. , 2007, Journal of clinical gastroenterology.
[67] S. Woods,et al. Prevalence of asymptomatic Clostridium difficile colonization in a nursing home population: a cross-sectional study. , 2003, The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia.
[68] Rob Knight,et al. UCHIME improves sensitivity and speed of chimera detection , 2011, Bioinform..
[69] Neil Stollman,et al. Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection , 2012, The American Journal of Gastroenterology.
[70] M. Taljaard,et al. The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital , 2012, Canadian Medical Association Journal.